According to estimates provided by data science company IQVIA, by 2022 global expenditure on pharmaceuticals will have risen to 1,430 billion, compared to 658 billion spent in 2006. Several factors are influencing this: urbanisation processes and a wider spread of chronic diseases, an ageing population and greater attention to health. Growing consumer demand has led to the emergence of new…